Penetration enhancers

被引:1331
|
作者
Williams, AC [1 ]
Barry, BW [1 ]
机构
[1] Univ Bradford, Sch Pharm, Drug Delivery Grp, Bradford BD7 1DP, W Yorkshire, England
关键词
penetration enhancers; accelerants; skin; lipids; azone; dimethylsulphoxide; terpenes;
D O I
10.1016/j.addr.2003.10.025
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
One long-standing approach for improving transdermal drug delivery uses penetration enhancers (also called sorption promoters or accelerants) which penetrate into skin to reversibly decrease the barrier resistance. Numerous compounds have been evaluated for penetration enhancing activity, including sulphoxides (such as dimethylsulphoxide, DMSO), Azones (e.g. laurocapram), pyrrolidones (for example 2-pyrrolidone, 2P), alcohols and alkanols (ethanol, or decanol), glycols (for example propylene glycol, PG, a common excipient in topically applied dosage forms), surfactants (also common in dosage forms) and terpenes. Many potential sites and modes of action have been identified for skin penetration enhancers; the intercellular lipid matrix in which the accelerants may disrupt the packing motif, the intracellular keratin domains or through increasing drug partitioning into the tissue by acting as a solvent for the permeant within the membrane. Further potential mechanisms of action, for example with the enhancers acting on desmosomal connections between corneocytes or altering metabolic activity within the skin, or exerting an influence on the thermodynamic activity/solubility of the drug in its vehicle are also feasible, and are also considered in this review. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:603 / 618
页数:16
相关论文
共 50 条
  • [1] Penetration enhancers
    Williams, Adrian C.
    Barry, Brian W.
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2012, 64 : 128 - 137
  • [2] Chemical penetration enhancers
    Lopes, Luciana B.
    Garcia, Maria Teresa J.
    Bentley, Maria Vitoria L. B.
    [J]. THERAPEUTIC DELIVERY, 2015, 6 (09) : 1053 - 1061
  • [3] Transdermal penetration enhancers
    Hrabálek, A
    Dolezal, P
    Sklubalová, Z
    Farsa, O
    Krebs, AA
    [J]. CHEMICKE LISTY, 1999, 93 (02): : 107 - 119
  • [4] Transdermal Penetration Enhancers
    Jessy, Shaji
    Shripad, Marathe
    Mansi, Shah
    [J]. CURRENT DRUG THERAPY, 2007, 2 (02) : 133 - 142
  • [5] TOPICAL PENETRATION ENHANCERS
    WOODFORD, R
    BARRY, B
    [J]. MANUFACTURING CHEMIST, 1987, 58 (04): : 49 - &
  • [6] Skin penetration enhancers
    Lane, Majella E.
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2013, 447 (1-2) : 12 - 21
  • [7] Penetration enhancers assessed by corneoxenometry
    Goffin, V
    Henry, F
    Piérard-Franchimont, C
    Piérard, GE
    [J]. SKIN PHARMACOLOGY AND APPLIED SKIN PHYSIOLOGY, 2000, 13 (05): : 280 - 284
  • [8] The role of percutaneous penetration enhancers
    Walker, RB
    Smith, EW
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 1996, 18 (03) : 295 - 301
  • [9] Percutaneous penetration enhancers: An overview
    Thong, H.-Y.
    Zhai, H.
    Maibach, H. I.
    [J]. SKIN PHARMACOLOGY AND PHYSIOLOGY, 2007, 20 (06) : 272 - 282
  • [10] FORMULATION OF PENETRATION ENHANCERS IN POLYMERS
    VIEGAS, TX
    HIKAL, AH
    CLEARY, RW
    [J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1988, 14 (06) : 855 - 866